Cardinal Health Raises 2025 Profit Outlook Again, Helped By Strong Drug Distribution Business

Friday, Cardinal Health Inc. (NYSE:CAH) reported first-quarter 2025 adjusted EPS of $1.88, up 9% year over year, beating the consensus of $1.62.

Sales decreased 4% to $52.28 billion, beating the consensus of $50.90 billion. Adjusted operating earnings increased 12% to $625 million.

First-quarter revenue for the Pharmaceutical and Specialty Solutions segment decreased by 5% to $48.0 billion. Excluding the customer contract expiration, revenue increased by 16%, driven by brand and specialty pharmaceutical sales growth from existing customers.

Pharmaceutical and Specialty Solutions segment profit increased 16% to $530 million, driven by a higher contribution from brand and specialty products, including the earlier seasonal launch of COVID-19 vaccine distribution and positive generics program performance.

The Pharmaceutical and Specialty Solutions segment distributes branded and generic pharmaceuticals, specialty drugs, and OTC products and offers services for ...